Dorsey Wright & Associates’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$468K Buy
+508
New +$515K 0.06% 142
2025
Q4
Sell
-468
Closed -$447K 99
2025
Q3
$357K Hold
468
0.08% 113
2025
Q2
$365K Hold
468
0.09% 113
2025
Q1
$387K Sell
468
-16,101
-97% -$13.4M 0.1% 108
2024
Q4
$12.8M Sell
16,569
-2,164
-12% -$1.79M 3.05% 2
2024
Q3
$16.6M Buy
18,733
+271
+1% +$244K 3.93% 1
2024
Q2
$16.7M Buy
18,462
+2
+0% +$1.6K 4.34% 1
2024
Q1
$14.4M Buy
18,460
+2,672
+17% +$1.9M 3.75% 1
2023
Q4
$9.2M Sell
15,788
-1,056
-6% -$616K 2.8% 1
2023
Q3
$9.05M Buy
16,844
+431
+3% +$222K 2.81% 1
2023
Q2
$7.7M Sell
16,413
-417
-2% -$175K 2.32% 2
2023
Q1
$5.78M Sell
16,830
-5,528
-25% -$1.86M 1.75% 6
2022
Q4
$8.18M Buy
+22,358
New +$7.93M 2.39% 2
2022
Q2
$2.5M Buy
7,714
+6,146
+392% +$1.84M 0.73% 71
2022
Q1
$449K Sell
1,568
-7,418
-83% -$1.91M 0.1% 106
2021
Q4
$2.48M Sell
8,986
-313
-3% -$79.3K 0.51% 92
2021
Q3
$2.15M Buy
+9,299
New +$2.3M 0.47% 99
2019
Q3
Sell
-2,651
Closed -$294K 315
2019
Q2
$294K Sell
2,651
-15,243
-85% -$1.8M 0.07% 122
2019
Q1
$2.32M Buy
17,894
+2,133
+14% +$259K 0.56% 76
2018
Q4
$1.82M Buy
+15,761
New +$1.76M 0.55% 77
2015
Q4
Sell
-5,158
Closed -$432K 117
2015
Q3
$432K Buy
+5,158
New +$435K 0.23% 69

Other funds holding LLY

Dorsey Wright & Associates's LLY Position: Q1 2026 in Review

Dorsey Wright & Associates opened a new position in Eli Lilly (LLY) in Q1 2026: 508 shares worth $468K. The stake represents 0.06% of the portfolio and ranks #142 among its holdings. This is a return to the name: Dorsey Wright & Associates previously reported a position in LLY as recently as Q3 2025.

Dorsey Wright & Associates first reported a position in LLY in Q3 2015 and has held it in 21 quarters since. The position peaked at $16.7M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Dorsey Wright & Associates held 508 shares of Eli Lilly worth $468K as of Q1 2026.
  • Eli Lilly was a new Dorsey Wright & Associates position in Q1 2026.
  • Eli Lilly made up 0.06% of Dorsey Wright & Associates's portfolio in Q1 2026, its #142 holding.
  • Dorsey Wright & Associates first reported a position in Eli Lilly in Q3 2015 and has held it in 21 quarters since.
  • Dorsey Wright & Associates's Eli Lilly position peaked at $16.7M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Dorsey Wright & Associates's 13F filing for Q1 2026, filed 6 May 2026.